Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
ShareThe year 2024 etched an indelible mark on Nigeria’s economic history as over 20 highprofile multinational corporations, including Unilever Nigeria Plc, Procter & Gamble, GlaxoSmithKline Consumer ...
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
Innovative therapies revive a once-undruggable mitochondrial aging regulator through a revolutionary enzyme activation ...
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, including Pfizer, Novo Nordisk and GlaxoSmithKline.
We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other cheapest stocks ...